rs7157609
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_006668.2(CYP46A1):c.-310G>A variant causes a upstream gene change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 145,408 control chromosomes in the GnomAD database, including 5,930 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.27 ( 5930 hom., cov: 23)
Consequence
CYP46A1
NM_006668.2 upstream_gene
NM_006668.2 upstream_gene
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -1.43
Publications
8 publications found
Genes affected
CYP46A1 (HGNC:2641): (cytochrome P450 family 46 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This endoplasmic reticulum protein is expressed in the brain, where it converts cholesterol to 24S-hydroxycholesterol. While cholesterol cannot pass the blood-brain barrier, 24S-hydroxycholesterol can be secreted in the brain into the circulation to be returned to the liver for catabolism. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.365 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| CYP46A1 | NM_006668.2 | c.-310G>A | upstream_gene_variant | ENST00000261835.8 | NP_006659.1 | |||
| CYP46A1 | XM_011536364.2 | c.-310G>A | upstream_gene_variant | XP_011534666.1 | ||||
| CYP46A1 | XM_017020933.3 | c.-467G>A | upstream_gene_variant | XP_016876422.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.272 AC: 39454AN: 145298Hom.: 5930 Cov.: 23 show subpopulations
GnomAD3 genomes
AF:
AC:
39454
AN:
145298
Hom.:
Cov.:
23
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.271 AC: 39456AN: 145408Hom.: 5930 Cov.: 23 AF XY: 0.274 AC XY: 19368AN XY: 70634 show subpopulations
GnomAD4 genome
AF:
AC:
39456
AN:
145408
Hom.:
Cov.:
23
AF XY:
AC XY:
19368
AN XY:
70634
show subpopulations
African (AFR)
AF:
AC:
5012
AN:
39416
American (AMR)
AF:
AC:
5061
AN:
14622
Ashkenazi Jewish (ASJ)
AF:
AC:
972
AN:
3412
East Asian (EAS)
AF:
AC:
1620
AN:
4734
South Asian (SAS)
AF:
AC:
1732
AN:
4558
European-Finnish (FIN)
AF:
AC:
3029
AN:
9374
Middle Eastern (MID)
AF:
AC:
77
AN:
282
European-Non Finnish (NFE)
AF:
AC:
21224
AN:
66140
Other (OTH)
AF:
AC:
514
AN:
2002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.513
Heterozygous variant carriers
0
1294
2589
3883
5178
6472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
404
808
1212
1616
2020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1244
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.